CATL, the world’s largest maker of batteries for electric vehicles, described breakthroughs that could make E.V.s more ...

CATL’s second-gen Shenxing LFP battery can deliver a range of 497 miles on a single charge and is capable of charging at a ...

The study's authors said ongoing disruptions could undo decades of progress to end HIV/AIDS as ... States to want to reduce its funding over time, but the sudden withdrawal of lifesaving support ...

“We are still a work in progress. We are not where we think we ... That was the plan from the get-go; we want to play one game at a time.” The 2025 BAL teams have been divided into three ...

The U.S. market showed signs of calming Tuesday as the Trump administration signaled progress on trade negotiations. "We were having a discussion last night about which countries to prioritize ...

TIME met the males (Khaleesi was not present ... the first edited animals that have come from the labs, both represent progress. Still, scientists not affiliated with the company stress that ...

Liverpool captain Virgil van Dijk has revealed there has been "progress" made in his contract negotiations amid continued speculation over his future at the club. Van Dijk's deal is set to expire ...

WASHINGTON (Reuters) - U.S. Secretary of State Marco Rubio and Indian Foreign Minister Subrahmanyam Jaishankar held a call on Monday to discuss U.S. tariffs on India and how to make progress ...

"They also discussed U.S. reciprocal tariffs on India and how to make progress toward a fair and balanced trade relationship," the State Department said in a statement. "Agreed on the importance ...

The vast majority of Medicare's top-selling brand-name oncology drugs in 2022 provided high added therapeutic benefit. Ten drugs were classified as low or no added therapeutic benefit compared ...

Simmering, low-key, before bringing it to a full boil this season, when they’ve reached the NCAA Tournament’s Final Four for the first time in program history. UCLA (34-2) will face perennial ...

Therefore, Senhwa will actively pursue licensing possibilities while carefully evaluating CX-4945’s potential as a monotherapy or in combination with the second-line immunotherapy Libtayo. The company ...